Ebselen has been studied for an array of diseases and has a very low toxicity. 191 ,  192 ,  193  Its safety has been demonstrated in clinical trials. 191 ,  192 ,  194  It can therefore be considered a promising molecule for the treatment or prevention of CoV infections.